Evidence map›Paper›PMID 30364170›Full record

ArticleFrontiers in microbiology2018

Novel Screen to Assess Bactericidal Activity of Compounds Against Non-replicating

Bryan J Berube, Lina Castro, Dara Russell, Yulia Ovechkina, Tanya Parish

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Reactive Oxygen Detoxification Contributes tobioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Insights intoFrontiers in cellular and infection microbiology · 2025
    Article
  10. Altered serine metabolism promotes drug tolerance inAntimicrobial agents and chemotherapy · 2024
    Article
  11. Antimicrobial and Antibiofilm Effects of Bithionol againstAntibiotics (Basel, Switzerland) · 2024
    Article
  12. Article
  13. Fate ofFrontiers in microbiology · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Mycobacterium abscessus drug discovery using machine learning.Tuberculosis (Edinburgh, Scotland) · 2022
    Article
  18. Review
  19. Antimicrobial agents and chemotherapy · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bryan J BerubeTB Discovery Research, Infectious Disease Research Institute, Seattle, WA, United States.
Lina CastroTB Discovery Research, Infectious Disease Research Institute, Seattle, WA, United States.
Dara RussellTB Discovery Research, Infectious Disease Research Institute, Seattle, WA, United States.
Yulia OvechkinaTB Discovery Research, Infectious Disease Research Institute, Seattle, WA, United States.
Tanya ParishTB Discovery Research, Infectious Disease Research Institute, Seattle, WA, United States.

Funding

Chemical probes of vulnerable pathways in antibiotic-resistant pathogensR01AI099188 · NIAID · ACCESS TO ADVANCED HEALTH INSTITUTE · PI PARISH, TANYA · 2012 to 2016
$3.7M
NIAID NIH HHS R01 AI099188
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

drug discoveryhigh-throughput screenMycobacterium abscessusniclosamidenon-replicatingnutrient starvation

Identifiers

PMID30364170
PMCPMC6191478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.